XML 40 R2.htm IDEA: XBRL DOCUMENT v3.2.0.727
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
 [1]
Current assets:    
Cash and cash equivalents $ 35,059 $ 22,781
Short-term investments 75,854 28,513
Investment in Aduro Biotech, Inc. 12,032  
Accounts receivable 5,425 5,493
Inventories 13,681 14,956
Prepaid expenses 1,009 1,210
Other current assets 1,411 1,932
Total current assets 144,471 74,885
Non-current assets:    
Property and equipment, net 3,816 3,781
Goodwill 1,316 1,316
Intangible assets, net 1,041 1,142
Restricted cash 622 508
Other assets 140 144
Total assets 151,406 81,776
Current liabilities:    
Accounts payable 5,765 9,882
Accrued liabilities 6,914 8,444
Accrued taxes 2,467  
Deferred revenue-current 577 376
Debt-current 2,523  
Warrant liability 3,978 10,485
Total current liabilities 22,224 29,187
Non-current liabilities:    
Debt-non-current 17,371 9,872
Deferred income taxes 122 115
Other non-current liabilities 1,160 1,081
Total liabilities $ 40,877 $ 40,255
Commitments and contingencies    
Stockholders' equity:    
Common stock $ 97 $ 80
Additional paid-in capital 670,327 583,416
Accumulated other comprehensive income (loss) 7,481 (31)
Accumulated deficit (567,376) (541,944)
Total stockholders' equity 110,529 41,521
Total liabilities and stockholders' equity $ 151,406 $ 81,776
[1] The financial information in this column was derived from audited consolidated financial statements included in the Company's 2014 Annual Report on Form 10-K.